This clinical observation indicates that thyroid function needs to be monitored during therapy with natalizumab, as with other biological medicines, and that thyroid volume and antibody modulation are predictive factors of functional evolution during and after treatment.
A case of thyroiditis during natalizumab therapy for multiple sclerosis
LARONI, ALICE;UCCELLI, ANTONIO;GIUSTI, MASSIMO
2011-01-01
Abstract
This clinical observation indicates that thyroid function needs to be monitored during therapy with natalizumab, as with other biological medicines, and that thyroid volume and antibody modulation are predictive factors of functional evolution during and after treatment.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
